Another rally on Wall Street and two strategists both say there’s more room to run…where they’re finding opportunities.
The CEO of AbCellera joins to discuss the company’s partnership with Eli Lilly in the race for a COVID-19 antibody drug.
And two policy strategists weigh in one of the biggest and most underappreciated risks for the market right now.
Plus, a ‘cool’ trade for the summer.

Room to Run, the Race for a COVID-19 Antibody Drug, and the Most Underappreciated Risk

"The Exchange" on CNBC is a one-stop shop for the day's top business stories, along with breaking news and the must-see market movers heading into the back half of the trading day. This newsroom-based program also features lots of original reporting, in-depth conversations and showcases CNBC's award-winning investigative work. "The Exchange" has all that plus "Rapid Fire," our innovative, reporter driven roundtable – which is a discussion of some of the day's most interesting, unusual and at times controversial topics. This series gives today's modern investor the day's top stories, the must reads & a whole lot more.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

News

Has the Fed’s base case shifted from “later cuts” to “no cuts this year?” Our market guest says it doesn’t matter. He sees stocks going higher regardless. He’ll tell us why, and the one scenario that could change it. Plus, credit card debt stands at a record high. At the same time, using buy now pay later to fund purchases remains popular. Klarna has its finger on both of these trends, and the CEO is here with what he’s seeing. And, a push to on-or near-shoring supply chains is making one sector increasingly attractive. We’ll tell you which one, and the names that stand to benefit the most.

No Cuts, No Problem?, Buy Now, Pain Later? & Supply Chain Winners  4/17/24

The bond market is keeping stock gains in check as we prepare to hear from Fed Chair Powell this hour. We’ll bring you the headlines and reaction from BNY Mellon’s CEO. Plus, the winners and losers ahead of REIT earnings as office vacancy rates hit a 20-year high. And housing starts just posted the biggest drop in 4 years, but one name is better-insulated from high rates, according to our analyst.

Catalysts & Concerns, REITs & Risks, Rates & Housing 4/16/24

Stocks sink after Israel vows to retaliate against Iran following its missile attack over the weekend. We discuss the ramifications across energy and defense and what it means for US foreign policy. Plus, Netflix kicks off big tech earnings later this week. Morgan Stanley’s Ben Swinburne joins with the key numbers to watch and why he sees $1000/share in the not-too-distant future.

Examining Geopolitical Risks and the Market Impact 4/15/24

We’re tracking the market sell-off to end the week, but our market guest says investors need to be selective to avoid a lost decade of gains ahead. Plus, venture capitalist and “Shark Tank” guest judge Matt Higgins joins us with where he sees the most risk and opportunity in the VC landscape right now. And Box CEO Aaron Levie is here to weigh in on the debate of whether AI will cut or create jobs.

Tracking the Sell-off, The VC View, Box CEO Aaron Levie 4/12/24

WeWork co-founder Adam Neumann is unveiling his new venture and spoke exclusively to our Deirdre Bosa about that and his bid to buy back WeWork. Plus, Bank of America says the Street is underestimating Apple’s pricing power ahead of its results and joins us to make his case. And the market is fixated on the macro, but that’s a good thing according to our market guest who says the setup into earnings couldn’t be better.

Room to Run, the Race for a COVID-19 Antibody Drug, and the Most Underappreciated Risk

Download our free app to listen on your phone